Published in Am J Cardiol on February 15, 1992
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A (1994) 8.92
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med (1994) 5.67
Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A (1989) 5.40
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol (1995) 4.31
Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol (1995) 2.98
Unresolved problems in coronary care. Am J Cardiol (1967) 2.59
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med (1993) 2.43
Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care (1996) 2.30
Regulation of cell proliferation by epidermal growth factor. CRC Crit Rev Biochem (1983) 2.09
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol (1999) 2.00
Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology (1994) 1.91
Molecular cloning of a gene sequence regulated by nerve growth factor. Science (1985) 1.88
Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol (1998) 1.67
Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. Eur Heart J (1999) 1.63
Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning. Am J Cardiol (1982) 1.59
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet (2001) 1.58
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol (1990) 1.58
Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci U S A (1993) 1.51
Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol (1994) 1.48
The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Arch Intern Med (1992) 1.47
Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation (1998) 1.47
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
Q wave and Non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol (1995) 1.41
Assessment of a creatine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "Shahal" experience. Crit Care Med (1999) 1.40
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Pronus angina (angina pectoris induced by stooping or crouching). A proposed mechanism. Chest (1993) 1.40
Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res (1993) 1.37
Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation (1979) 1.36
VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front Neuroendocrinol (2000) 1.36
Mobility, clustering, and transport of nerve growth factor in embryonal sensory cells and in a sympathetic neuronal cell line. Proc Natl Acad Sci U S A (1980) 1.33
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc Natl Acad Sci U S A (2006) 1.30
The early recognition of right ventricular infarction: diagnostic accuracy of the electrocardiographic V4R lead. Circulation (1983) 1.30
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene (1993) 1.30
Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J (1975) 1.24
Unsuspected cerebral perfusion. A complication of the use of a central venous pressure catheter. Chest (1978) 1.22
Lifestyle intervention on diet and exercise reduced excessive gestational weight gain in pregnant women under a randomised controlled trial. BJOG (2011) 1.22
Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol (1990) 1.21
Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest (1983) 1.15
Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide. FEMS Microbiol Lett (2004) 1.14
Headache in schizophrenic patients: a controlled study. Cephalalgia (1999) 1.13
Identification of neonatal hearing impairment: hearing status at 8 to 12 months corrected age using a visual reinforcement audiometry protocol. Ear Hear (2000) 1.12
Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent. Am J Cardiol (1979) 1.12
Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation (1981) 1.12
Procainamide-induced left anterior hemiblock of the 2:1 type (pseudoelectrical alternans). Chest (1978) 1.10
Cerebral and cardiac toxicity of a small dose of lignocaine. Br Heart J (1975) 1.09
Ultrasonic validation of residual bladder volume in postvaginal hysterectomy patients. Gynecol Obstet Invest (1991) 1.09
Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation (2000) 1.08
A cross-sectional study on compulsive behaviour (stable vices) in horses. Equine Vet J Suppl (1998) 1.08
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
Verapamil-digoxin interaction. N Engl J Med (1980) 1.07
Sectral in the management of angina pectoris. S Afr Med J (1973) 1.07
Unusual QRS morphology associated with transvenous pacemakers. The pseudo RBBB pattern. Chest (1985) 1.06
Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J (1981) 1.06
Hypothalamic expression of a novel gene product, VGF: immunocytochemical analysis. J Neurosci (1989) 1.05
Comparison of 12- and 72-hour expectant management of premature rupture of membranes in term pregnancies. Obstet Gynecol (1995) 1.04
Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man. S Afr Med J (1973) 1.04
Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. Clin Ther (1999) 1.04
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993. Diabetes Care (1997) 1.04
Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler (2007) 1.03
The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J Am Coll Cardiol (1999) 1.03
The beneficial effects of verapamil in chronic atrial fibrillation. Arch Intern Med (1979) 1.03
Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor. J Neurochem (2002) 1.02
Induction of cell attachment and morphological differentiation in a pheochromocytoma cell line and embryonal sensory cells by the extracellular matrix. Dev Biol (1982) 1.02
Acquired left ventricular-right atrial communication caused by infective endocarditis detected by transesophageal echocardiography: case report and review of the literature. J Am Soc Echocardiogr (1995) 1.02
Two-dimensional echocardiography in detection of endocardial cushion defect in families. Am J Cardiol (1985) 1.02
Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host. Clin Exp Immunol (2003) 1.02
Dibenzepin as an antifibrillatory agent for spontaneously terminating electrically induced ventricular fibrillation. Isr J Med Sci (1979) 1.01
Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. Chest (1977) 1.00
Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut (1988) 1.00
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99
Factors influencing the duration of exclusive breastfeeding in a group of Turkish women. J Hum Lact (2001) 0.99
Direct medical cost of chronic obstructive pulmonary disease in the U.S.A. Respir Med (2000) 0.99
Tissue-specific processing of the neuroendocrine protein VGF. J Neurochem (1995) 0.98
Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J (1993) 0.97
Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A). Br Heart J (1973) 0.97
Randomised double blind trial of morphine versus diamorphine for sedation of preterm neonates. Arch Dis Child Fetal Neonatal Ed (1998) 0.97
The development of the complement system after 28 weeks' gestation. Acta Paediatr (1997) 0.96
Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells. Endocrinology (1999) 0.96
Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol (1998) 0.96
A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. EMBO J (1989) 0.96
Weight change and lung cancer: relationships with symptom distress, functional status, and smoking. Res Nurs Health (1994) 0.96
Nerve growth factor potentiates actomyosin adenosinetriphosphatase. Proc Natl Acad Sci U S A (1978) 0.95
The influence of verapamil on serum digoxin concentration. Circulation (1982) 0.94
Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation (1981) 0.93
Bradyarrhythmias: clinical significance and management. J Am Coll Cardiol (1983) 0.93
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol (1993) 0.93
Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group. Am J Med (1991) 0.93
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br J Pharmacol (2009) 0.92